Abstract
Umicore will acquire Evonik Industries’ intellectual property for metathesis chemistry and cross-coupling catalysis for an undisclosed sum. Metathesis chemistry is suitable for making complex molecules required by pharmaceutical and fine chemical companies and more, Umicore says. The deal follows Umicore’s purchase of Materia’s olefin metathesis catalyst business in 2018 for $27 million. In 2017, Materia lost a legal case in the US against Evonik relating to the validity of its metathesis patents.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.